Jun 20
Registration statement
S-3
Registration statement
FBIO · Fortress Biotech, Inc. · Documents
$1.99
-0.02 (-1.00%)
At close · Nov 12
Return incl. dividend (before tax)
Q3 2025 earnings call transcript
Market Cap
$73.19M
Shares
36.78M
Volume · Nov 12
297.96K
Avg daily vol (3M)
315.02K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2024
May 29
Current report
8-K
Events of May 23
Director or officer change, or executive pay, Shareholder vote results
May 29
Registration statement
S-3/A
Registration statement
May 17
Registration statement
S-3
Registration statement
May 15
Current report
8-K
Financial results
May 15
Quarterly report
10-Q
FY2024 Q1, ended Mar 31
Quarterly report for FY2024 Q1
Revenue $13.03M
▲ 4.8%
Net loss $15.42M
Apr 5
Proxy statement
DEF 14A
Meeting May 23, 2024
Proxy statement
Apr 5
Proxy statement
DEFA14A
Proxy statement
Mar 28
Current report
8-K
Financial results
Mar 28
Annual report
10-K
FY2023, ended Dec 31
Annual report for FY2023
Revenue $84.51M
▲ 11.6%
Net loss $60.64M
Diluted EPS -$8.47
Jan 26
Current report
8-K
Events of Jan 25
Director or officer change, or executive pay
Jan 3
Current report
8-K
Events of Dec 29
Entered into a material agreement, Other events
2023
Nov 14
Current report
8-K
Events of Nov 9
Entered into a material agreement, Other events
Nov 14
Current report
8-K
Financial results
Nov 14
Quarterly report
10-Q
FY2023 Q3, ended Sep 30
Quarterly report for FY2023 Q3
Revenue $34.75M
▲ 110.3%
Net loss $5.05M
Diluted EPS -$0.94
Oct 26
Current report
8-K
Events of Oct 24
Other events
Oct 10
Current report
8-K
Events of Oct 9
Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change, Shareholder vote results, Other events
Aug 25
Proxy statement
DEF 14A
Meeting Oct 9, 2023
Proxy statement
Aug 25
Proxy statement
DEFA14A
Proxy statement
Aug 15
Proxy statement
PRE 14A
Meeting Oct 9, 2023
Proxy statement
Aug 14
Current report
8-K
Events of Aug 10
Financial results, Charter or bylaw amendment, or fiscal year change
Aug 14
Quarterly report
10-Q
FY2023 Q2, ended Jun 30
Quarterly report for FY2023 Q2
Revenue $17.39M
▼ 7.9%
Net loss $24.78M
Diluted EPS -$0.24
Jun 23
Current report
8-K
Events of Jun 21
Director or officer change, or executive pay, Shareholder vote results
Jun 16
Current report
8-K
Events of Jun 13
Entered into a material agreement, Change to shareholders' rights
May 15
Current report
8-K
Financial results
May 15
Quarterly report
10-Q
FY2023 Q1, ended Mar 31
Quarterly report for FY2023 Q1
Revenue $12.43M
▼ 48.1%
Net loss $21.54M
Diluted EPS -$0.21
May 5
Current report
8-K
Events of May 2
Delisting notice or listing transfer
Apr 28
Proxy statement
DEF 14A
Meeting Jun 21, 2023
Proxy statement
Apr 28
Proxy statement
DEFA14A
Proxy statement
Apr 13
Current report
8-K
Events of Apr 10
Shareholder vote results
Apr 7
Registration statement
S-3/A
Registration statement
Mar 31
Annual report
10-K
FY2022, ended Dec 31
Annual report for FY2022
Revenue $75.74M
▲ 10.1%
Net loss $86.58M
Diluted EPS -$0.97
Mar 30
Current report
8-K
Financial results
Mar 13
Proxy statement
DEF 14A
Meeting Apr 10, 2023
Proxy statement
Mar 3
Proxy statement
PRE 14A
Meeting Apr 10, 2023
Proxy statement
Feb 10
Registration statement
S-3
Registration statement
Feb 9
Current report
8-K
Events of Feb 7
Entered into a material agreement, Other events
2022
Dec 19
Current report
8-K
Events of Dec 14
Entered into a material agreement, Director or officer change, or executive pay
Nov 14
Earnings call
Q3 2022 earnings call
Nov 14
Current report
8-K
Financial results
Nov 14
Quarterly report
10-Q
FY2022 Q3, ended Sep 30
Quarterly report for FY2022 Q3
Revenue $16.53M
▼ 21.6%
Net loss $22.51M
Diluted EPS -$0.25
Nov 4
Current report
8-K
Events of Oct 31
Delisting notice or listing transfer
Oct 28
Current report
8-K
Events of Oct 26
Director or officer change, or executive pay
Aug 11
Earnings call
Q2 2022 earnings call
Aug 11
Current report
8-K
Financial results
Aug 11
Quarterly report
10-Q
FY2022 Q2, ended Jun 30
Quarterly report for FY2022 Q2
Revenue $18.89M
▲ 5.8%
Net loss $21.36M
Diluted EPS -$0.24
Jul 22
Current report
8-K
Events of Jul 21
Director or officer change, or executive pay
Jul 11
Current report
8-K
Charter or bylaw amendment, or fiscal year change
Jun 27
Current report
8-K
Events of Jun 21
Director or officer change, or executive pay, Shareholder vote results
May 17
Proxy statement
DEFA14A
Proxy statement
Showing 51–100 of 160 documents
Key facts
CIK
1429260
CUSIP
34960Q307
13F (30d)
44 filings
31 filers
Visit website
Investor relations